Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Health insurers will not be covering the cost of a new obesity medication coming on to the market in Ireland. Mounjaro, a ...

As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...

While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

At medical conferences and hospital cafeterias, one thing has become increasingly clear—many doctors are using Ozempic, ...

According to Bank of America, several companies are prime candidates for a stock split in the near future, which could lead ...

We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against ...